<DOC>
	<DOCNO>NCT02944487</DOCNO>
	<brief_summary>The objective study evaluate safety tolerability lucerastat , determine pharmacokinetic profile single oral dos different strength .</brief_summary>
	<brief_title>A Study Assess Safety Pharmacokinetics Lucerastat ( OGT 923 ) Healthy Subjects</brief_title>
	<detailed_description>The subject enrol sequentially five dose group , start low dose level . Subjects could participate one Group .</detailed_description>
	<criteria>Signed informed consent form . Male subject age 18 45 year screen . Body weight 50 100 kg body mass index ( BMI ) 18.0 29.0 kg/m2 screening . Healthy basis physical examination , cardiovascular assessment laboratory test . History clinical evidence disease medical / surgical condition treatment , may put subject risk participation study may interfere absorption , distribution , metabolism excretion study treatment . Serious adverse reaction hypersensitivity drug . Any circumstance condition , , opinion investigator , may affect full participation study compliance protocol .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>safety</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>